Absci (ABSI) Other Working Capital Changes (2020 - 2026)
Absci (ABSI) posted Other Working Capital Changes of -$83000.0 for Q1 2026, down 122.62% sequentially from $367000.0 in Q4 2025, and down 1285.71% YoY from $7000.0 in Q1 2025.
Powered by 
Analysis
Absci (ABSI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Absci has reported Other Working Capital Changes for 7 years, with the latest figure at -$83000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 1285.71% year-over-year to -$83000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31000.0 (up 98.95% YoY) and the FY2025 annual result came in at $59000.0, up 101.95% from the prior year.
- Other Working Capital Changes fell to -$83000.0 in Q1 2026 per ABSI's latest filing, from $367000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.1 million in Q3 2025 and troughed at -$1.8 million in Q1 2022.
- A 5-year average of -$130000.0 and a median of -$477000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 753.18% in 2024, down 1597.87% in 2024.
- Over 5 years, Other Working Capital Changes stood at $1.4 million in 2022, then surged by 199.21% to $4.2 million in 2023, then tumbled by 204.07% to -$4.3 million in 2024, then surged by 108.45% to $367000.0 in 2025, then sank by 122.62% to -$83000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$83000.0, $367000.0, and -$189000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 301,000.00 |
| Jun 30, 2026 | 301,000.00 |
| Mar 31, 2026 | -83,000.00 |
| Mar 31, 2026 | -83,000.00 |
| Dec 31, 2025 | -401,000.00 |
| Dec 31, 2025 | -401,000.00 |
| Sep 30, 2025 | 622,000.00 |
| Sep 30, 2025 | 622,000.00 |
| Jun 30, 2025 | -142,000.00 |
| Jun 30, 2025 | -142,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | -665,000.00 |
| Dec 31, 2024 | -665,000.00 |
| Sep 30, 2024 | -191,000.00 |
| Sep 30, 2024 | -191,000.00 |
| Jun 30, 2024 | -1.27 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -898,000.00 |
| Mar 31, 2024 | -898,000.00 |